Harnessing Characterization & Analytical Methods to Illuminate LNP Structure & Enable Stability, Integrity, & Efficacy for Regulatory Submissions & Next Generation Constructs
As RNA therapeutics move toward targeted delivery, multi-cargo constructs and gene editing, lipid nanoparticle characterization has become critical to understanding drug product quality, predicting performance and meeting regulatory expectations.
The 4th LNP Characterization & Analytical Development Summit is the only meeting dedicated entirely to solving the analytical challenges of LNP drug products.
If you're a scientist running the assays, instruments and methods every day, this is your opportunity to learn how peers at AbbVie, Merck, Genentech, Sanofi, Eli Lilly and Novo Nordisk tackle challenges ranging from SAXS and mass spectrometry to RiboGreen encapsulation efficiency. If you're leading an LNP pipeline, this is where your team can stay ahead of evolving analytical requirements, improve development readiness and gain practical insight into targeted LNPs, complex payloads and emerging modalities.
Over two days of practitioner-led case studies, panels and roundtables, you'll:
- Strengthen your control strategy by defining the critical quality attributes (CQAs) that actually predict potency, safety and efficacy
- Get practical answers on what's next for targeted LNPs, taRNA, in vivo CAR-T and gene editing LNPs
- Compare leading analytical platforms side by side at a neutral, independently run event
- Exchange insights directly with experts from big pharma and next-generation biotech in a focused setting designed for meaningful discussion
Leave with proven approaches, valuable industry connections and a clearer roadmap for advancing analytical development across your LNP pipeline.
Comprehensive sharing of cutting-edge methodologies for LNP characterization, including physicochemical techniques, potency assays, and in vitro–in vivo correlation, among others.
Tong Liu, Senior Principal Scientist
U.S Pharmacopeia
I appreciate very much the Hanson Wade conference series on LNP characterization. It brings together hands-on experts from different sides and allows in-debth exchange on a scientific level.
Heinrich Haas, Chief Technology Officer
NeoVac
Great small meeting that allowed for meaningful connections with everyone. Well-designed and engaging. Definitely will attend again!
Boguslaw Nocek, Senior Director
Eli Lilly & Co
Explore the Full Event Guide
- Get the complete event agenda, speaker faculty, and session highlights in one place
- Explore the latest topics shaping the future of LNP characterization and analytical development
- Preview key sessions covering predictive CQAs, targeted LNPs, multi-cargo systems, and advanced analytics
- Discover networking, poster presentation, and collaboration opportunities available onsite
- Share with colleagues and align your team on the sessions and insights not to miss
A Snapshot of Industry-Leading Speakers
2026 Official Partners
Attending Companies Include
Explore Related Events
Explore the Agenda
Discover the latest advances in LNP characterization and analytical development through expert-led presentations, interactive discussions, and technical case studies.
Partner With Us
Position your brand alongside industry leaders and connect directly with decision-makers advancing next-generation RNA and LNP therapeutics.
Join Industry Leaders
Connect with analytical, characterization, formulation, and CMC experts to exchange insights and build valuable partnerships across the LNP community.